FBB Biomed
FBB Biomed is a biotechnology research company developing RNA-based systems biology analytics for neurology and chronic disease research. Its platform uses RNA-sequencing data to assess activity across interconnected biological systems, with the aim of supporting research stratification and longitudinal monitoring. Its current platform is described as being available for research use only.
Visit WebsiteAbout FBB Biomed
FBB Biomed is a biotechnology company based in Iowa that applies RNA systems biology, bioinformatics, and computational analysis to the study of complex diseases. Its RNA Systems Intelligence platform analyzes non-coding RNA expression patterns from RNA-sequencing data to estimate activity across biological systems rather than focusing on a single biomarker or pathway.
The company’s current focus includes neurology research and the potential use of its platform to stratify participants and monitor responses in clinical-stage programs. Its stated audiences include biopharmaceutical companies and laboratories that already have RNA-sequencing capabilities.
FBB Biomed’s broader scientific vision is to develop a more comprehensive, longitudinal view of health and disease using molecular data. Its website currently describes the platform as research use only, so its test should not be represented as an approved clinical diagnostic.